FORM 8-K

Company

INTEGRATED BIOPHARMA INC

Filed

June 21, 2022

Period of Report

June 20, 2022

Accession Number

0001437749-22-015503

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →